Key Takeaways
What Is the Best Magnesium for Anxiety and Depression? The Short Answer
Ask what is the best magnesium for anxiety and depression and the trial record gives no single winner, because no study has compared magnesium forms head to head on mood. The form with the most direct evidence is magnesium chloride: in a 2017 University of Vermont trial, 248 mg of elemental magnesium a day for six weeks was followed by a net 6.0-point drop on the PHQ-9 depression scale and a 4.5-point drop on the GAD-7 anxiety scale[1].
That trial had no placebo, and placebo-controlled studies are less encouraging: a 2018 meta-analysis linked magnesium to lower depression scores in uncontrolled studies but not in placebo-controlled ones[3]. Prevalence figures for depression and anxiety are on the condition pages; this post covers which magnesium forms were tested and what they showed.
Chloride, oxide, aspartate, sulfate and glycinate have all been used in depression studies[2][8]. None of the seven trials in a 2023 meta-analysis reported using L-threonate, taurate or malate, the forms most often marketed for the brain[2].
Net improvement in PHQ-9 depression scores after 6 weeks of magnesium chloride
126 primary care adults with mild-to-moderate depression took 248 mg a day of elemental magnesium, compared with 6 weeks of no treatment. Participants knew when they were taking magnesium, so expectation effects cannot be ruled out.
"net improvement in PHQ-9 scores of -6.0 points"
Which Magnesium Forms Have Been Tested for Depression?
Most magnesium depression trials are small and short, and they differ in dose, duration and the scale used to score depression, which makes ranking forms unreliable[2]. What each form has shown so far:
Magnesium chloride
The Vermont trial gave four 500 mg magnesium chloride tablets a day, which supplied 248 mg of elemental magnesium[1]. Benefits appeared within two weeks and were similar regardless of age, sex, baseline severity, baseline magnesium level or antidepressant use[1].
An earlier trial in 23 older adults with type 2 diabetes and low blood magnesium gave 450 mg of elemental magnesium a day as a magnesium chloride solution[9]. After 12 weeks, depression scores were similar to those on imipramine 50 mg, a tricyclic antidepressant[9].
Magnesium oxide
In a double-blind trial of 60 depressed adults with low serum magnesium, two 250 mg magnesium oxide tablets a day for eight weeks lowered Beck Depression Inventory-II scores by 15.65 points, compared with 10.40 points on placebo[4]. By the end, 88.5% of the magnesium group had normal magnesium levels, against 48.1% of the placebo group[4].
Magnesium aspartate
A double-blind study in Warsaw added 120 mg a day of magnesium as aspartate, or placebo, to fluoxetine in 37 adults with recurrent depression[5]. Depression scores did not differ between the groups at any point over eight weeks[5]. In a multivariate analysis of the whole group, though, receiving magnesium was among the factors linked to higher odds of response and remission[5].
Magnesium glycinate
The only depression study of glycinate added 800 mg of magnesium glycinate, or 112 mg of elemental magnesium, to standard antidepressants in 44 patients[8]. By day 28, PHQ-9 scores had improved 72.17% with magnesium versus 26.42% with antidepressants alone, but patients were not randomized and knew which group they were in[8].
Magnesium Forms Tested in Depression Trials
| Form | Study | Participants | Daily dose | Design | Result |
|---|---|---|---|---|---|
| Chloride | Tarleton 2017 | 126 adults, mild-moderate depression | 248 mg elemental, 6 wk | Open-label crossover, no placebo | PHQ-9 −6.0; GAD-7 −4.5 (net) |
| Chloride | Barragán-Rodríguez 2008 | 23 older adults, type 2 diabetes, low Mg | 450 mg elemental, 12 wk | Randomized vs. imipramine | Similar to imipramine 50 mg |
| Oxide | Rajizadeh 2017 | 60 adults, low Mg | 500 mg MgO, 8 wk | Double-blind vs. placebo | BDI-II −15.65 vs. −10.40 |
| Aspartate | Ryszewska-Pokraśniewicz 2018 | 37 adults on fluoxetine | 120 mg Mg, 8 wk | Double-blind vs. placebo | No difference in HDRS |
| Glycinate | Siddique 2026 | 44 adults on antidepressants | 112 mg elemental, 28 days | Open-label, nonrandomized | PHQ-9 improved 72.17% vs. 26.42% |
1Doses are elemental magnesium where the study reported it; the oxide trial reported compound weight.
2BDI-II = Beck Depression Inventory-II; HDRS = Hamilton Depression Rating Scale; PHQ-9 = Patient Health Questionnaire-9; GAD-7 = Generalized Anxiety Disorder-7.
Sources
- •PLOS ONE, 2017
- •Magnesium Research, 2008
- •Nutrition, 2017
- •Nutrients, 2018
- •Naunyn-Schmiedeberg's Archives of Pharmacology, 2026
Does Magnesium Work for Depression? What the Meta-Analyses Found
The two main meta-analyses point in different directions. A 2023 review in Frontiers in Psychiatry pooled seven randomized placebo-controlled trials with 325 adults and found a large drop in depression scores with magnesium (standardized mean difference −0.92, 95% CI −1.44 to −0.40)[2].
Heterogeneity in that review was high (I² = 75.6%), and only two of the seven trials were rated low risk of bias across all domains[2]. The effect was larger in trials run in Iran and was not significant in trials that used the Beck Depression Inventory[2].
A 2018 meta-analysis in BJPsych Open pooled 11 supplementation studies with 714 participants[3]. The benefit was confined to uncontrolled studies (Hedges' g −1.62); in placebo-controlled trials it was small and not statistically significant (g −0.22, 95% CI −0.48 to 0.17)[3].
Those authors concluded that their results provided little evidence for a role of magnesium in mood disorders[3]. The 2023 authors called for larger, high-quality trials before the effect is applied in clinical settings[2]. Neither review compared one magnesium form against another.
Is the Evidence for Anxiety Any Stronger?
No. Anxiety trials mostly enrolled people with anxiety-prone conditions rather than diagnosed anxiety disorders. A 2017 systematic review of 18 studies found positive effects in 4 of 8 studies of mildly anxious samples, 4 of 7 in premenstrual syndrome and 1 of 2 in hypertension, and no effect on postpartum anxiety[6].
The reviewers rated the quality of that evidence as poor and called for well-designed randomized trials[6].
The Vermont chloride trial is one of the few that scored depression and anxiety in the same people, and GAD-7 anxiety scores improved by a net 4.5 points[1]. It is the closest direct evidence for the combined question, with the caveat that it had no placebo arm and neither participants nor investigators were blinded[1].
Anxiety-only findings, including magnesium combined with vitamin B6, are covered in magnesium for anxiety. Sleep trials of bisglycinate and L-threonate are in which magnesium is best for sleep and anxiety.
Elemental magnesium
The weight of magnesium itself in a supplement, as opposed to the weight of the whole compound in which magnesium is bound to chloride, oxide, glycine or another carrier. In the Vermont trial, four 500 mg magnesium chloride tablets supplied 248 mg of elemental magnesium[1]; in the glycinate study, 800 mg of magnesium glycinate supplied 112 mg[8].
Related Terms
Source: Tarleton et al., PLOS ONE 2017; Siddique et al., Naunyn-Schmiedeberg's Archives of Pharmacology 2026
Glycinate, Citrate, Threonate or Chloride: Does Absorption Matter for Mood?
Absorption differs by form, but higher absorption has not been shown to produce a bigger mood effect. The NIH Office of Dietary Supplements says forms that dissolve well in liquid are absorbed more completely, and that aspartate, citrate, lactate and chloride tend to have higher bioavailability than magnesium oxide and magnesium sulfate[7].
That ranking does not match the depression results. Magnesium oxide, one of the less bioavailable forms, outperformed placebo in the double-blind trial above[4], while aspartate showed no difference from placebo when added to fluoxetine[5].
Glycinate, also sold as bisglycinate, is the form most often marketed for mood, yet its one depression study was nonrandomized[8]. No depression trial of magnesium citrate, L-threonate, taurate or malate appears among the seven trials in the 2023 meta-analysis[2].
Blood tests add another complication. Less than 1% of the body's magnesium is in serum, and serum levels do not accurately reflect total body magnesium[7]. Two of the positive trials enrolled only people with low serum magnesium[4][9], while the Vermont trial found similar effects regardless of baseline magnesium[1].
How Much Magnesium Did Depression Trials Use, and How Fast?
Oral doses in the trials above ranged from 112 mg of elemental magnesium a day as glycinate[8] to 450 mg a day as a chloride solution[9]. The adult Tolerable Upper Intake Level for supplemental magnesium is 350 mg a day[7], so the 450 mg dose exceeded it.
The recommended dietary allowance from all sources is 400 to 420 mg a day for adult men and 310 to 320 mg for adult women[7]. In NHANES 2013–2016, 48% of Americans took in less magnesium from food and beverages than their estimated average requirement[7].
In the 2023 meta-analysis, trials using 250 mg a day or less showed a larger effect than higher-dose trials (SMD −1.39 vs. −0.62), but the low-dose group contained only three effect sizes[2]. The authors described this as a possible stronger effect, not an established dose-response[2].
On timing, PHQ-9 scores in the Vermont trial fell within two weeks, and the effect had partly faded within two weeks of stopping[1]. The glycinate study reported a 41.34% improvement by day 14[8]. The longest trial here lasted 12 weeks[9], and the Vermont authors note that long-term effectiveness is unknown[1].
Magnesium With Antidepressants: Interactions, Side Effects and Regulation
Several trials gave magnesium alongside antidepressants: fluoxetine in the Warsaw study[5], escitalopram, sertraline, duloxetine, amitriptyline or fluoxetine in the glycinate study[8], and stable antidepressant use was allowed in the Vermont trial[1]. None of the trials in the 2023 meta-analysis reported adverse effects from magnesium[2].
In the Vermont trial, diarrhea was the most common side effect, reported by 8 participants, and one person withdrew after two weeks because of nausea and lethargy[1].
High doses of supplemental magnesium can cause diarrhea, nausea and abdominal cramping, and very high doses can cause magnesium toxicity with low blood pressure and irregular heartbeat[7]. Magnesium can reduce absorption of oral bisphosphonates and binds tetracycline and quinolone antibiotics; loop and thiazide diuretics and long-term proton pump inhibitor use can deplete magnesium[7].
Magnesium products sold over the counter are dietary supplements. The FDA does not approve supplements before they are marketed, and a product claiming to treat, prevent or cure a disease is regulated as a drug[10].
Treatments with larger evidence bases are compared in anti-depression meds, and other supplement evidence for anxiety is in supplements for anxiety.
Frequently Asked Questions
Sources & References
- Tarleton EK, Littenberg B, MacLean CD, Kennedy AG, Daley C. Role of magnesium supplementation in the treatment of depression: A randomized clinical trial. PLOS ONE. Published 2017. Accessed October 2026. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0180067 [Link]
- Moabedi M, Aliakbari M, Erfanian S, Milajerdi A. Magnesium supplementation beneficially affects depression in adults with depressive disorder: a systematic review and meta-analysis of randomized clinical trials. Frontiers in Psychiatry. Published 2023. Accessed October 2026. https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2023.1333261/full [Link]
- Phelan D, Molero P, Martínez-González MA, Molendijk M. Magnesium and mood disorders: systematic review and meta-analysis. BJPsych Open. Published 2018. Accessed October 2026. https://www.cambridge.org/core/journals/bjpsych-open/article/magnesium-and-mood-disorders-systematic-review-and-metaanalysis/9257DB9E4EAC7F0A5C5B84E63B4D3AEF [Link]
- Rajizadeh A, Mozaffari-Khosravi H, Yassini-Ardakani M, Dehghani A. Effect of magnesium supplementation on depression status in depressed patients with magnesium deficiency: A randomized, double-blind, placebo-controlled trial. Nutrition. Published 2017. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/28241991/ [Link]
- Ryszewska-Pokraśniewicz B, Mach A, Skalski M, et al. Effects of Magnesium Supplementation on Unipolar Depression: A Placebo-Controlled Study and Review of the Importance of Dosing and Magnesium Status in the Therapeutic Response. Nutrients. Published 2018. Accessed October 2026. https://www.mdpi.com/2072-6643/10/8/1014 [Link]
- Boyle NB, Lawton C, Dye L. The Effects of Magnesium Supplementation on Subjective Anxiety and Stress: A Systematic Review. Nutrients. Published 2017. Accessed October 2026. https://www.mdpi.com/2072-6643/9/5/429 [Link]
- Office of Dietary Supplements. Magnesium: Fact Sheet for Health Professionals. National Institutes of Health. Published 2026. Accessed October 2026. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/ [Link]
- Siddique A, Naeem U, Khokhar MM, et al. Clinical evaluation of adjunctive magnesium therapy in patients receiving antidepressants for depression: open label, nonrandomized clinical trial. Naunyn-Schmiedeberg's Archives of Pharmacology. Published 2026. Accessed October 2026. https://link.springer.com/article/10.1007/s00210-026-05540-1 [Link]
- Barragán-Rodríguez L, Rodríguez-Morán M, Guerrero-Romero F. Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial. Magnesium Research. Published 2008. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/19271419/ [Link]
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements. U.S. Food and Drug Administration. Published 2026. Accessed October 2026. https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements [Link]